Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Silent SNPs: impact on gene function and phenotype.

Anton A Komar1

  • 1Cleveland State University, Department of Biological, Geological and Environmental Sciences, Cleveland, OH 44115, USA. a.komar@csuohio.edu

Pharmacogenomics
|August 25, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

METTL16 promotes taxane resistance in Triple-Negative Breast Cancer through m <sup>6</sup> A-dependent translational upregulation of ABCB1.

bioRxiv : the preprint server for biology·2026
Same author

Cell Lines CoCoPUTs: A Database of Codon and Codon-pair Usage Frequencies in Cell Lines.

Journal of molecular biology·2026
Same author

Uncovering position-specific patterns in codon and codon-pair usage in candidate genes associated with blood coagulation diseases.

NAR genomics and bioinformatics·2025
Same author

Myeloid-specific deficiency of ribosomal protein L13a alters macrophage polarity and diversity during differentiation from bone marrow.

Journal of leukocyte biology·2025
Same author

Uncovering codon usage patterns during murine embryogenesis and tissue-specific developmental diseases.

Frontiers in genetics·2025
Same author

Therapeutic implications of synonymous gene recoding: insights into mechanisms controlling protein biogenesis and activity.

Protein & cell·2025
Same journal

Closely similar tacrolimus morning troughs and graft function across the recipients' common <i>ABCB1</i> polymorphisms (<i>c.2677G>T/A</i>, <i>c.1236C>T</i>, <i>c.3435C>T</i>) early after renal transplantation.

Pharmacogenomics·2026
Same journal

Pharmacogenomics for stratified antidepressant treatment in major depressive disorder: evidence, limits and a roadmap for clinical use.

Pharmacogenomics·2026
Same journal

Guidance from an informed public on collecting and sharing PGx test results for major depressive disorder: "It's no different from your blood type".

Pharmacogenomics·2026
Same journal

Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery models.

Pharmacogenomics·2026
Same journal

Combinations of single gene predictors with AI-driven polygenic precision therapies in cardiovascular diseases.

Pharmacogenomics·2026
Same journal

Practical guide to implementing pre-emptive pharmacogenetic screening in routine pediatric oncology care.

Pharmacogenomics·2026
See all related articles

Silent single nucleotide polymorphisms (SNPs) in the MDR1 gene can alter P-glycoprotein conformation and function, impacting drug metabolism. These genetic variations should be considered in personalized medicine and disease risk assessment.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Genetics

Background:

  • Silent single nucleotide polymorphisms (SNPs) in the Multidrug Resistance 1 (MDR1) gene, encoding P-glycoprotein, have been linked to altered drug pharmacokinetics.
  • The mechanisms behind these effects, especially when mRNA and protein expression levels remain unchanged, are not well understood.

Purpose of the Study:

  • To investigate the ex vivo effects of three specific MDR1 polymorphisms (C1236T, G2677T, C3435T) on P-glycoprotein expression and activity.
  • To elucidate how silent SNPs influence P-glycoprotein function and substrate specificity.

Main Methods:

  • Ex vivo cell-based analysis of MDR1 gene polymorphisms.
  • Assessment of P-glycoprotein expression, conformation, and activity.

Related Experiment Videos

Main Results:

  • Silent polymorphisms, particularly C3435T in the MDR1 gene, were shown to alter P-glycoprotein conformation.
  • These alterations in protein structure lead to changes in P-glycoprotein activity and substrate specificity.
  • This study provides the first evidence that silent SNPs can produce functionally distinct proteins with identical amino acid sequences.

Conclusions:

  • Silent SNPs in the MDR1 gene can significantly impact P-glycoprotein function and substrate specificity without altering expression levels.
  • These findings necessitate a re-evaluation of the role of silent SNPs in disease susceptibility and drug response.
  • The results underscore the importance of considering silent SNPs in personalized drug treatment and development strategies.